Quick Answer
Nautilus Biotechnology, Inc. reported Net Income of -$59.00 million for fiscal year 2025.
Nautilus Biotechnology, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$59.00M | +16.6% |
| 2024 | -$70.78M | -11.2% |
| 2023 | -$63.67M | -9.9% |
| 2022 | -$57.92M | -15.1% |
| 2021 | -$50.31M | -222.1% |
| 2020 | -$15.62M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.57M | +17.5% | +9.7% |
| June 30, 2025 | -$15.03M | +16.5% | +9.5% |
| March 31, 2025 | -$16.61M | +11.3% | -1.0% |
| September 30, 2024 | -$16.45M | -3.6% | +8.7% |
| June 30, 2024 | -$18.01M | -13.9% | +3.8% |
| March 31, 2024 | -$18.73M | -25.2% | -18.0% |
| September 30, 2023 | -$15.88M | -12.9% | -0.4% |
| June 30, 2023 | -$15.81M | -7.6% | -5.6% |
- Nautilus Biotechnology, Inc. showed an increase of +16.6% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Nautilus Biotechnology, Inc.’s net income has declined by 277.8% (from -$15.62 million to -$59.00 million).
- The most recent figure is from Nautilus Biotechnology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: